The Prevalence of Extended Spectrum Beta-Lactamase Producing Uropathogenic Escherichia coli from Mouau Female Hostel Students
South Asian Journal of Research in Microbiology, Volume 13, Issue 4,
Aim: The study is aimed at determining the antimicrobial susceptibility pattern and production of Extended-spectrum Βeta-Lactamase (ESBLs) among Escherichia coli isolates from urine samples.
Methods: A total of 35 samples of early morning mid-stream urine samples of about 10-15 ml were collected from Michael Okpara University of Agriculture Umudike (MOUAU) female hostel students; using sterile plastic containers. Each urine sample was inoculated on MacConkey Agar (MCA). Isolates were identified based on morphological features, Gram staining, and biochemical characterization. The antibiotic susceptibility test was done by the Kirby Bauer Disc diffusion method on Muller Hinton agar. ESBL detection was done as per Clinical and Laboratory Standard Institute (CLSI) guidelines, using the double disc synergy test method.
Results: The study reviewed a total of 12 isolates of Escherichia coli of which is (34.29%) of which were obtained from urine samples. The susceptibility test results showed that most isolates were susceptible to Ofloxacin with 83.3% susceptibility, followed by Levofloxacin (66.7%), whereas gentamicin, nalidixic acid, cefuroxime, and cefotaxime exhibited a susceptibility rate of 33.3%. On the other hand, the highest resistance rate was to imipenem (96.7%), followed by Amoxicillin and ampiclox with 83.3%, while the least percentage resistance was observed in Ofloxacin with (8.3%) and Levofloxacin with (16.7%). Extended-spectrum Βeta-Lactamase (ESBLs) production among E. coli isolates was detected in 25.0% of the potential ESBL producers. The result of the multiple antibiotic resistance index showed that the isolate (E20) was significantly higher than other isolates with p<0.05, whereas E3, E7, E10 and E12 had same resistance pattern.
Conclusion: So drug resistance due to ESBL production is a severe threat in UTIs, narrowing down the choice of antibiotics for treatment. So, there is a need to introduce routine screening for ESBL production for all uropathogenic Escherichia coli, causing urinary tract infections.
How to Cite
Khan IU, Mirza IA, Ikram A, Afzal A, Ali S, Hussain A. Antimicrobial susceptibility pattern of bacteria isolated from patients with urinary tract infection. J Coll Phys Surg Pak. 2014;24(11): 840-844.
Beyene G, Tsegaye W. Bacterial uropathogens in urinary tract infection and antibiotic susceptibility pattern in Jimma university hospital, Ethiopia. Ethiopian J Health Sci. 2011;21:141-146.
Minardi D, D'Anzeo G, Cantoro D, Conti A, Muzzonigro, G. Urinary tract infections in women: etiology and treatment options. International J Gen Med. 2011;4:333-343.
Singhal A, Sharma R, Jain M. Hospital and community isolates of uropathogens and their antibiotic sensitivity pattern from a tertiary care hospital in North West India. Annual Med Health Sci Res. 2014;4(1):51 56.
Hamdan Z, Ziad A, Haliem MA, Salah K, Ishag A. Epidemiology of urinary tract infections and antibiotics sensitivity among pregnant women at Khartoum North Hospital, Annual Clin Microbiol Antimicrobial. 2011;10(2):1–5.
Nas FS, Ali M, Abdallah MS, Zage AU. Prevalence and antibiotic susceptibility pattern of Escherichia coli isolated from urine samples of urinary tract infection patients. J Urology. 2019;4(1):14-20.
Mustafa SR, Ritu G, Varsha AS, Dipankar B. Antibiotic susceptibility profile and extended-spectrum β-lactamases production by uropathogenic Escherichia coli from tertiary care hospital of rural settings. Intern J Res in Med Sci. 2018; 6(12):4022-4027.
Banerjee S, Sengupta M. Sarker TK. Fosfomycin susceptibility among multidrug-resistant, extended-spectrum beta-lactamase-producing, carbapenem-resistant uropathogens. Indian J Urology. 2017;33(2):149-154.
Halwarkar AK, Sataraddi J, Gupta S, Yoganand R, Rao A. Srinivasa H. The detection of ESBL-producing Escherichia coli in patients with symptomatic urinary tract infections using different diffusion methods in a rural setting. J Infection and Pub Health. 2013;6:108-114.
Cheesbrough M. District laboratory practice in tropical countries. (Part 2) Cambridge University Press, United Kingdom; 2006.
Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing, 31st informational supplement (M100-S20). Clinical and Laboratory Standards Institute, Wayne, PA, USA; 2021.
Clinical Laboratory Standards Institute (CLSI), M100: Performance standards for antimicrobial susceptibility testing, CLSI, Wayne, PA, USA, 30th Edition; 2020.
Mingxi H, Can Z, Yufei M, Qianwei S. and Yongjun F. Indian indole affects biofilm formation in bacteria. Journal of Microbiology. 2010;12:362–368.
Al-Baer A, Hussein AA. Isolation and identification of Escherichia coli producing cytosine deaminase from iraqi patients. Int. J. Adv. Res. Biol. Sci. 2017;4(11):1-6.
Van Belkum A, Welker M, Erhard M, Chatellier S. Biomedical mass spectrometry intoday's and tomorrow's clinical microbiology laboratories. J Clin Microbiol. 2012;50:1513–1517.
Kithar R. Majeed, Talib A. Jaayid, Salah N.A. Al-Khaeun. Isolation and identification of some types bacteria from shrimp (Metapenaeus affinis) and detection of histamine producing from its Metapenaeus affinis. Basrah Journal of Agricultural Sciences. 2016;29(1):35-56.
Rahman MS, Garg R, Singh VA. Biswas D. Antibiotic susceptibility profile and extended-spectrum β-lactamases production by uropathogenic Escherichia coli from tertiary care hospital of rural settings. International Journal of Research in Medical Sciences. 2018;6(12):4022-4027.
Cortes-Penfield NW, Trautner BW, Jump RLP. Urinary tract infection and asymptomatic bacteriuria in older adults. Infectious Dis Clin North America. 2017; 31(4):673-688.
Sabir S, Anjum AA, Ijaz T, Ali MA, Khan MR, Nawaz M. Isolation and antibiotic susceptibility of E. coli from urinary tract infections in a tertiary care hospital. Pak J Med Sci. 2014;30(2):389-392.
Petkovs¡ek Z, Elers¡ic¡ K, Gubina M, Z¡gurBertok D, Erjavec S. Virulence potential of Escherichia coli isolates from skin and soft tissue infections. J Clin Microbiol. 2009;47(6):1811–1817.
Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Disease. 2018;8(3):159-166.
Ikeda Y, Mamiya T, Nishiyama H, Koseki T, Mouri A, Nabeshima T. Risk factors for extended-spectrum β-lactamase-producing Escherichia coli infection in hospitalized patients. Nagoya J Med Sci. 2012;74(1–2):105.
Fennell J, Vellinga A, Hanahoe B, Morris D, Boyle F and Higgins F. Increasing prevalence of ESBL production among Irish clinical Enterobacteriaceae from 2004 to 2008: an observational study. British Mol Coun Infectious Dis. 2012;12(1):116.
Abstract View: 317 times
PDF Download: 80 times